Immunohistochemistry (IHC) revealed heterogeneous expression patterns of CD39 throughout MC38 tumors, with strong expression of CD39 among cells infiltrating the tumor and those accumulated at the tumor borders (Figure 1A). This evidence concerns the gene ENTPD1 and neoplasm.